Template:Lymphadenopathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 28: | Line 28: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Lymphadenopathy classification | [[Lymphadenopathy historical perspective|Historical Perspective]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Lymphadenopathy classification|Classification]] | |||
|- | |- | ||
! | ! | ||
| Line 52: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Lymphadenopathy epidemiology and demographics|Epidemiology | [[Lymphadenopathy epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
| Line 64: | Line 70: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Lymphadenopathy natural history|Natural History, Complications and Prognosis]] | [[Lymphadenopathy screening|Screening]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Lymphadenopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]] | |||
|- | |- | ||
! | ! | ||
| Line 88: | Line 100: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Lymphadenopathy laboratory | [[Lymphadenopathy laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
| Line 94: | Line 106: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Lymphadenopathy x ray|X Ray]] | [[Lymphadenopathy electrocardiogram|Electrocardiogram]] | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Lymphadenopathy chest x ray|Chest X Ray]] | |||
|- | |- | ||
! | ! | ||
| Line 112: | Line 130: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Lymphadenopathy ultrasound|Ultrasound]] | [[Lymphadenopathy echocardiography or ultrasound|Echocardiography or Ultrasound]] | ||
|- | |- | ||
! | ! | ||
| Line 143: | Line 161: | ||
! | ! | ||
[[Lymphadenopathy surgery|Surgery]] | [[Lymphadenopathy surgery|Surgery]] | ||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Lymphadenopathy primary prevention|Primary Prevention]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Lymphadenopathy secondary prevention|Secondary Prevention]] | |||
|- | |- | ||
! | ! | ||
| Line 150: | Line 180: | ||
[[Lymphadenopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Lymphadenopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
| Line 156: | Line 186: | ||
[[Lymphadenopathy future or investigational therapies|Future or Investigational Therapies]] | [[Lymphadenopathy future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
| Line 166: | Line 196: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Lymphadenopathy|Case #1]] | [[Lymphadenopathy case study one|Case #1]] | ||
|- | |- | ||
! | ! | ||
| Line 231: | Line 261: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num= | [http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse] | ||
|- | |- | ||
! | ! | ||
| Line 261: | Line 291: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on{{PAGENAME}}] | [http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}] | ||
|- | |- | ||
! | ! | ||
| Line 267: | Line 297: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Lymphadenopathy}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab= | [http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Lymphadenopathy}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Lymphadenopathy] | ||
|- | |- | ||
! | ! | ||
Revision as of 17:33, 8 March 2013
|
Lymphadenopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphadenopathy On the Web |
|
American Roentgen Ray Society Images of Lymphadenopathy |